Topic Archives: Revance Therapeutics (RVNC)

Comments

  • SoGiAm

    TTG Top Aggressive #option activity CALLS: $TEVA $VRX $WDC $MDT $ETSY $INTC $XLE $MAC $RVNC $PZZA $JACK $GSK $CRR $MO...

  • SoGiAm

    Upcoming December catalysts + Wk in Review + #ASH17 $ACRS $BIIB $CELG $GALT $KALA $MDGL $MLNT $NVO $PTI $RVNC $SAGE ht...

  • Dr. KSS MD PhD

    This is just NOT a stock I plan to be involved in. The lead product is an optimized botulinum toxin with an extended dur...

  • SoGiAm

    $CAPR xxOWxx ADDED, $BPMX long $LPTX In $RVNC TD because of No TICKER! Please us $XYZ ticker and position in EACH post...

  • SoGiAm

    $RVNC np - In terms of biotech investing, I tend to be someone who likes being involved in product development for disea...

  • SoGiAm

    $rvnc np via Ajgormican ;-) Revance Therapeutics,, a violitile share price with this one, but it’s starting to look...

  • SoGiAm

    Revance $RVNC crashes hard as ph2 data show no way for advancing to phase3. I would gently remind people: in late win...

  • SoGiAm

    $RVNC https://www.stockgumshoe.com/2014/05/microblog-hepatitis-with-a-c-right-now-someone-you-know-has-it-and-doesnt-kno...

  • SoGiAm

    $RVNC np - http://www.revance.com/ #Focus! https://docs.google.com/spreadsheets/d/1tyFFLmr6QymjbC5JS95V4wqdQl-Sw11nIGE...

  • Avatar

    Hi Doc, all. Revance Therapeutics ($RVNC) I have been pondering playing another catalyst play before the end of th...

  • Avatar

    $rvnc np Revance Therapeutics,, a violitile share price with this one, but it's starting to look cheap again. I know an...

  • SoGiAm

    #Biotech Data in June (Updated) via @AndyBiotech $ANTH IgA $ADMS MS $CCXI Ph2 $CYAD CHF $EPZM NHL $GWPH Ph3 $HRT...

  • Gui_

    Latest pipeline updates for ADXS CEMP CHMA CLBS CTIC CVM CYTK DERM KMDA OCRX ONTX ORMP RVNC SYN TKAI BioPharmCat...

  • Avatar

    It seems that folks are in the need to make immediate winners as soon as a stock is touted by a newsletter. I subscribed...

  • Travis Johnson, Stock Gumshoe

    Don't know if others were following this, but it looks like RVNC was hyped up pretty heavily by Agora Financial's FD...

  • Dr. KSS, MD PhD

    Revance $RVNC crashes hard as ph2 data show no way for advancing to phase3. I would gently remind people: in late wi...

  • Dr. KSS, MD PhD

    David: first, I totally agree about Sinovac. I myself have voiced concerns about Asian science here, both on the basis o...

  • Avatar

    I've noticed that some of our more recent stocks of interest are coming from biotechs that have had an IPO in the past y...

  • Avatar

    According to Money Map Press, these bio stocks are on sale? Thoughts welcome... Profit Machine No. 1 Auspex Pharmaceu...

  • Avatar

    I have greatly enjoyed reading most of these postings, and I want to give back something from what I have learned. I wi...

  • Avatar

    I am fortunate in being able to obtain occasional allocations of IPO stocks. Several years ago, I received an allocatio...

  • Avatar

    Dr karma, Thanks for your insightful comments on RVNC. It’s very helpful. Will close it after flipping period is over...

  • Avatar

    Re: post 423. Dr. Karma, With so many new issues flooding the market, the chance of a Joe average like me to spot a dia...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch